Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0040822 (
tremor
)
18,428
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have developed a new method for separation of antibody bound and unbound enzyme conjugates. The technique as applied to the assay of
choriomammotropin
involves the use of beta-D-galactosylamine bound to agarose to separate the unbound
choriomammotropin
-beta-galactosidase conjugates for antibody bound conjugates. When beta-galactosidase was conjugated with
choriomammotropin
using the N-hydroxy-succinamide ester of m-maleimidobenzoic acid the affinity of the enzyme conjugate to beta-D-galactosylamine attached to agarose diminished markedly following incubation with antibody. In a typical enzyme immunoassay of
choriomammotropin
, 5 microliter of swelled affinity gel per tube was required to precipitate unbound enzyme following one hour gentle
shaking
at room temperature.
Choriomammotropin
antibody was used at titer of 1:1,000. The standard curve for the assay was adjusted to cover a range of 0-10 mg/l with maximum sensitivity between 1-4 mg/l.
...
PMID:Steric hindrance enzyme immunoassay (SHEIA); a novel method in enzyme immunoassay. 39 Jun 56